ADAPTIMMUNE THERAPEUTICS PLC (ADAPY)

Import this data to Google Sheets with:

=jivedata("ADAPY","financials")

Full statements spill as a table. For one cell: =jivedata("ADAPY","Revenue") or =jivedata("ADAPY","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

ADAPTIMMUNE THERAPEUTICS PLC

ADAPY • CIK 0001621227

(in thousands, except per share data)	FY 2022	FY 2023	FY 2024	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$27,148	$60,281	$178,032	$65,085
Operating Income (Loss)	$-163,965	$-139,741	$-68,760	$-164,220
Investment Income, Nonoperating	—	—	$6,596	$5,018
InterestExpenseNonoperating	—	—	$3,348	$5,665
Other Nonoperating Income (Expense)	$-536	$-807	$-1,726	$-1,178
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-162,959	$-112,535	$-67,238	$-166,045
Income Tax Expense (Benefit)	$2,497	$1,336	$3,576	$3,711
Net Income (Loss) Attributable to Parent	$-165,456	$-113,871	$-70,814	$-169,756
Cost of Goods and Services Sold	—	—	$70	$3,450
Research and Development Expense	$127,726	$126,509	$149,060	$125,241
Selling, General and Administrative Expense	—	—	$87,261	$90,213
Impairment of Long-Lived Assets Held-for-use	—	—	$10,401	$10,401
Costs and Expenses	$191,113	$200,022	$246,792	$229,305
Weighted Average Number of Shares Outstanding, Basic	967,242,403	1,206,440,978	1,513,810,852	1,584,882,373

(in thousands, except per share data)	FY 2022	FY 2023	FY 2024	TTM
Cash and Cash Equivalents, at Carrying Value	$108,033	$143,991	$91,139	$26,061
Debt Securities, Available-for-sale, Current	$96,572	$2,947	$60,466	$0
Restricted Cash and Cash Equivalents, Noncurrent	$1,569	$3,026	$2,067	$1,717
Accounts Receivable, after Allowance for Credit Loss, Current	$7,435	$821	$1,454	$9,313
Other Assets, Noncurrent	—	—	$629	$94
Inventory, Net	—	—	$7,320	$11,411
Operating Lease, Right-of-Use Asset	$18,019	$20,762	$19,909	$18,748
Prepaid Expense and Other Assets, Current	$43,330	$59,793	$27,790	$31,330
Property, Plant and Equipment, Net	$53,516	$50,946	$31,309	$28,152
Assets, Current	$255,370	$207,552	$188,169	$78,115
Intangible Assets, Net (Excluding Goodwill)	$442	$330	$3,880	$3,807
Assets	$328,916	$282,616	$245,963	$130,633
Operating Lease, Liability, Noncurrent	$20,349	$19,851	$19,263	$18,491
Deferred Revenue, Noncurrent	—	—	$95,815	$95,979
Long-term Debt, Excluding Current Maturities	—	—	$50,237	$25,675
Other Liabilities, Noncurrent	$1,296	$1,404	$4,272	$4,493
Liabilities	$247,038	$243,103	$234,114	$201,591
Accounts Payable, Current	$4,753	$8,128	$8,692	$9,418
Operating Lease, Liability, Current	$2,728	$5,384	$4,709	$4,514
Accrued Liabilities, Current	$31,215	$30,303	$32,919	$24,526
Restructuring Reserve	$2,285	$2,285	$5,911	$2,355
Contract with Customer, Liability, Current	$23,520	$28,973	$12,296	$10,700
Liabilities, Current	$64,501	$72,788	$64,527	$51,513
Common Stock, Value, Issued	$1,399	$1,865	$2,085	$2,156
Additional Paid in Capital	$990,656	$1,064,569	$1,105,653	$1,109,409
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-875	$-3,748	$-1,902	$-10,612
Retained Earnings (Accumulated Deficit)	$-909,302	$-1,023,173	$-1,093,987	$-1,171,911
Stockholders' Equity Attributable to Parent	$81,878	$39,513	$11,849	$-70,958
DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLossCurrent	—	$2,940	$60,451	$0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Current	—	$0	$0	$0
Accounts Receivable, Allowance for Credit Loss, Current	$0	$0	$0	$0
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	$38,588	$46,020	$51,893	$75,028
Finite-Lived Intangible Assets, Accumulated Amortization	$4,676	$5,155	$5,567	$6,141
Common Stock, Shares Authorized	1,282,773,750	1,702,760,280	2,039,252,874	2,108,130,546
Common Stock, Shares, Issued	987,109,890	1,363,008,102	1,535,653,620	1,590,309,546

(in thousands, except per share data)	FY 2022	FY 2023	FY 2024	TTM
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$-165,456	$-113,871	$-70,814	$-169,756
Net Cash Provided by (Used in) Operating Activities	$-141,769	$-140,880	$-73,206	$-190,027
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$-2,299	$877	$-402	$0
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-42,064	$37,415	$-53,811	$-186,898
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$109,602	$147,017	$93,206	$-7,318
Depreciation	$5,266	$9,453	$10,814	$9,977
Payments to Acquire Property, Plant, and Equipment	$29,496	$4,681	$886	$1,640
Amortization	$809	$387	$411	$651
Payments to Acquire Intangible Assets	$244	$199	$1,834	$1,834
Impairment of Long-Lived Assets Held-for-use	—	—	$10,401	$10,401
Cash Acquired from Acquisition	—	$45,264	$45,264	$45,264
Business Combination, Bargain Purchase, Gain Recognized, Amount	—	$22,049	$22,049	$22,049
Proceeds from Sale and Maturity of Marketable Securities	$166,994	$210,983	$44,057	$44,057
Share-based Payment Arrangement, Noncash Expense	$18,240	$11,773	$12,051	$7,881
Payments to Acquire Marketable Securities	$48,117	$75,953	$100,418	$100,418
Foreign Currency Transaction Gain (Loss), Unrealized	$2,438	$-198	$-1,995	$-1,373
Proceeds from Sale of Other Assets, Investing Activities	—	$1,124	$129	$180
Net Cash Provided by (Used in) Investing Activities	$89,137	$176,538	$-58,952	$1,793
Other Operating Activities, Cash Flow Statement	$816	$167	$182	$236
Proceeds from Issuance of Long-term Debt	—	—	$49,500	$49,500
Increase (Decrease) in Inventories	—	—	$7,355	$7,355
Proceeds from Issuance of Common Stock	$12,817	$624	$29,172	$1,776
Increase (Decrease) in Other Noncurrent Assets	$-2,458	—	$642	$642
Proceeds from Stock Options Exercised	$50	$256	$77	$11
Increase (Decrease) in Accounts Payable and Other Operating Liabilities	$4,408	$-9,087	$9,619	$-2,800
Net Cash Provided by (Used in) Financing Activities	$12,867	$880	$78,749	$1,336
Increase (Decrease) in Contract with Customer, Liability	$3,874	$-14,574	$-69,795	$-36,358
Proceeds from Interest Received	$5,149	$4,748	$5,309	$5,309
Interest Paid, Excluding Capitalized Interest, Operating Activities	—	—	$2,092	$2,092
Investment Income, Net, Amortization of Discount and Premium	$-2,525	$1,986	$-1,267	$-1,267
Proceeds from Income Tax Refunds	—	$4,000	$1,525	$1,525

Jive Data

Google Sheets add-onSheets Account

Import this data to Google Sheets with:

=jivedata("ADAPY","financials")

Full statements spill as a table. For one cell: =jivedata("ADAPY","Revenue") or =jivedata("ADAPY","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.